by Regardless that in the previous couple of years a number of households of eukaryotic β-barrel outer membrane proteins (OMPs) have been found, their computational characterization and their annotation in public databases is way from full. The PFAM database consists of solely only a few attribute profiles for these households and, usually, the profile Hidden Markov Fashions (pHMMs) have been educated utilizing prokaryotic and eukaryotic proteins collectively. Right here, we current for the primary time a complete computational evaluation of eukaryotic transmembrane β-barrels.
12 attribute pHMMs have been constructed, primarily based on an in depth literature search, that may discriminate eukaryotic β-barrels from different courses of proteins (globular and bacterial β-barrel ones), in addition to between mitochondrial and chloroplastic ones. We constructed eight novel profiles for the chloroplastic β-barrel households that aren’t current within the PFAM database and, additionally, up to date the profile for the MDM10 household (PF12519) in PFAM and break up the porin household (PF01459) into two separate households, particularly VDAC and TOM40. Transmembrane signaling proteins play an important function within the transduction of knowledge throughout cell membranes.
One operate of regulated intramembrane proteolysis (RIP) is the discharge of signaling elements from transmembrane proteins. To check the function of transmembrane domains (TMDs) in modulating construction and exercise of launched signaling elements, we purified heterologously expressed human transmembrane proteins and their proteolytic processing merchandise from Escherichia coli. Right here we present that CD74 and TNFα are heme binding proteins. Heme coordination relies on each a cysteine residue proximal to the membrane and on the oligomerization of the TMD. Moreover, we present that the assorted processing merchandise have completely different modes of heme coordination. We recommend that RIP modifications the mode of heme binding of those proteins and generates heme binding peptides with but unexplored features. The identification of a RIP modulated cofactor binding of transmembrane signaling proteins sheds new gentle on the regulation of cell signaling pathways.
Exercise-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse major cortical neurons.
Mutations of PRRT2 (proline-rich transmembrane protein 2) trigger a number of neurological issues, represented by paroxysmal kinesigenic dyskinesia (PKD), which is characterised by assaults of involuntary actions triggered by sudden voluntary actions. PRRT2 is reported to suppress neuronal excitation, however it’s unclear how the operate of PRRT2 is modulated throughout neuronal excitation. We discovered that PRRT2 is processed to a 12 kDa carboxy-terminal fragment (12Okay-CTF) by calpain, a calcium-activated cysteine protease, in a neuronal activity-dependent method, predominantly through NMDA receptors or voltage-gated calcium channels. Moreover, we clarified that 12Okay-CTF is generated by sequential cleavages at Q220 and S244. The amino-terminal fragment (NTF) of PRRT2, which corresponds to PKD-related truncated mutants, just isn’t detected, in all probability attributable to speedy cleavage at a number of positions. On condition that 12Okay-CTF lacks many of the proline-rich area, this cleavage may be concerned within the activity-dependent enhancement of neuronal excitation maybe via transient retraction of PRRT2’s operate.
Subsequently, PRRT2 would possibly function a buffer for neuronal excitation, and lack of this operate in PKD sufferers would possibly trigger neuronal hyperexcitability of their motor circuits. Transporters mediate the motion of compounds throughout the membranes that separate the cell from its surroundings and throughout the inside membranes surrounding mobile compartments. It’s estimated that one third of a proteome consists of membrane proteins, and plenty of of those are transport proteins. Given the rise within the variety of genomes being sequenced, there’s a want for computational instruments that predict the substrates which can be transported by the transmembrane transport proteins. On this paper, we current TranCEP, a predictor of the kind of substrate transported by a transmembrane transport protein.
TranCEP combines the standard use of the amino acid composition of the protein, with evolutionary info captured in a a number of sequence alignment (MSA), and restriction to necessary positions of the alignment that play a job in figuring out the specificity of the protein. Our experimental outcomes present that TranCEP considerably outperforms the state-of-the-art predictors. The outcomes quantify the contribution made by every sort of knowledge used.
The Transmembrane Protein Semi1 Positions Gamete Nuclei for Reciprocal Fertilization in Tetrahymena.
Throughout sexual copy within the ciliate, Tetrahymena thermophila, cells of complementary mating sort pair (“conjugate”) bear simultaneous meiosis and fertilize one another. In each mating companions solely one of many 4 meiotic merchandise is “chosen” to flee autophagy, and this nucleus divides mitotically to supply two pronuclei. The migrating pronucleus of 1 cell translocates to the mating companion and fuses with its stationary pronucleus and vice versa. Collection of the designated gametic nucleus was thought to depend upon its place inside the cell as a result of it all the time attaches to the junction with the companion cell.
 Seven Transmembrane Helix Receptor Antibody |
|||
| ABD10214 | Lifescience Market | 100 ug | EUR 438 |
Seven Transmembrane Helix Receptor Antibody |
|||
| 44575-100ul | SAB | 100ul | EUR 252 |
Seven Transmembrane Helix Receptor Antibody |
|||
| 44575-50ul | SAB | 50ul | EUR 187 |
Seven Transmembrane Helix Receptor Antibody |
|||
| DF10214 | Affbiotech | 200ul | EUR 304 |
|
Description: Seven Transmembrane Helix Receptor Antibody detects endogenous levels of total Seven Transmembrane Helix Receptor. |
|||
 Seven Transmembrane Helix Receptor Conjugated Antibody |
|||
| C44575 | SAB | 100ul | EUR 397 |
 Seven Transmembrane Helix Receptor Blocking Peptide |
|||
| DF10214-BP | Affbiotech | 1mg | EUR 195 |
 Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
 OR Antibody |
|||
| 20-abx217389 | Abbexa |
|
|
|
|||
OR Antibody |
|||
| ABD10250 | Lifescience Market | 100 ug | EUR 438 |
OR Antibody |
|||
| 44609-100ul | SAB | 100ul | EUR 252 |
OR Antibody |
|||
| 44609-50ul | SAB | 50ul | EUR 187 |
OR Antibody |
|||
| DF10250 | Affbiotech | 200ul | EUR 304 |
|
Description: OR Antibody detects endogenous levels of total OR. |
|||
 polyclonal antibody) EGF, latrophilin and seven transmembrane domain containing 1 (ELTD1) polyclonal antibody |
|||
| ABP-PAB-10203 | Allele Biotech | 100 ug | Ask for price |
|
|||
 Antibody) EGF, Latrophilin And Seven Transmembrane Domain-Containing Protein 1 (Eltd1) Antibody |
|||
| abx432647-200ul | Abbexa | 200 ul | EUR 286 |
|
|||
EGF, Latrophilin And Seven Transmembrane Domain-Containing Protein 1 (Eltd1) Antibody |
|||
| abx432648-200ul | Abbexa | 200 ul | EUR 286 |
|
|||
 Antibody) EGF, Latrophilin And Seven Transmembrane Domain-Containing Protein 1 (ELTD1) Antibody |
|||
| 20-abx249473 | Abbexa |
|
|
|
|||
 OR Conjugated Antibody |
|||
| C44609 | SAB | 100ul | EUR 397 |
 Antibody) Helix Loop Helix Protein 2 (NHLH2) Antibody |
|||
| abx028957-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Helix Loop Helix Protein 2 (NHLH2) Antibody |
|||
| abx028957-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 Anti-Transmembrane protein 37 antibody |
|||
| STJ71308 | St John's Laboratory | 100 µg | EUR 260 |
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 10 (MLLT10) polyclonal antibody |
|||
| ABP-PAB-10850 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) polyclonal antibody |
|||
| ABP-PAB-10851 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 2 (MLLT2) polyclonal antibody |
|||
| ABP-PAB-10852 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 (MLLT3) polyclonal antibody |
|||
| ABP-PAB-10853 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 4 (MLLT4) polyclonal antibody |
|||
| ABP-PAB-10854 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 6 (MLLT6) polyclonal antibody |
|||
| ABP-PAB-10855 | Allele Biotech | 100 ug | Ask for price |
|
|||
 polyclonal antibody){kind=spacer} Myeloid/lymphoid or mixed-lineage leukemia translocated to 7 (MLLT7) polyclonal antibody |
|||
| ABP-PAB-10856 | Allele Biotech | 100 ug | Ask for price |
|
|||
 Antibody) Related To Receptor Tyrosine Kinase (RYK) Antibody |
|||
| 20-abx129056 | Abbexa |
|
|
|
|||
Related To Receptor Tyrosine Kinase (RYK) Antibody |
|||
| 20-abx103651 | Abbexa |
|
|
|
|||
 Antibody) Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx117192-100ug | Abbexa | 100 ug | EUR 467 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| 20-abx001679 | Abbexa |
|
|
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx012035-100ul | Abbexa | 100 ul | EUR 411 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| 20-abx012432 | Abbexa |
|
|
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx031140-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx031140-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx031180-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx031180-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx015819-100ul | Abbexa | 100 ul | EUR 411 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx015820-100ul | Abbexa | 100 ul | EUR 411 |
|
|||
 Antibody) Folliculogenesis Specific Basic Helix-Loop-Helix (FIGLA) Antibody |
|||
| abx029947-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Folliculogenesis Specific Basic Helix-Loop-Helix (FIGLA) Antibody |
|||
| abx029947-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| 20-abx328242 | Abbexa |
|
|
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx332062-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| abx432510-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) Antibody |
|||
| 20-abx211828 | Abbexa |
|
|
|
|||
 Cadherin EGF LAG seven-pass G-type receptor 2 Antibody |
|||
| 48039-100ul | SAB | 100ul | EUR 333 |
Cadherin EGF LAG seven-pass G-type receptor 2 Antibody |
|||
| 48039-50ul | SAB | 50ul | EUR 239 |
 antibody) Anti-Renalase (aa 224 to 233) antibody |
|||
| STJ70700 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-Renalase (aa 134 to 147) antibody |
|||
| STJ71208 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-ABHD4 (aa 177 to 187) antibody |
|||
| STJ71325 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-MAP3K7IP3 (aa 274 to 285) antibody |
|||
| STJ71330 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-MAP3K7IP3 (aa 59 to 69) antibody |
|||
| STJ71341 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-ABHD4 (aa 304 to 316) antibody |
|||
| STJ71344 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-SOX8 (aa 247 to 258) antibody |
|||
| STJ71374 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-GOT2 (aa 360 to 373) antibody |
|||
| STJ71375 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-SOX8 (aa 203 to 217) antibody |
|||
| STJ71391 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-GOT2 (aa 295 to 306) antibody |
|||
| STJ71437 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-GADD45gamma (aa 18 to 28) antibody |
|||
| STJ71440 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-GADD45gamma (aa 123 to 133) antibody |
|||
| STJ71441 | St John's Laboratory | 100 µg | EUR 260 |
){kind=spacer} Polyclonal CALCR / Calcitonin Receptor Antibody (Transmembrane Domain) |
|||
| APR01935G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CALCR / Calcitonin Receptor (Transmembrane Domain). This antibody is tested and proven to work in the following applications: |
|||
 Cadherin EGF LAG seven-pass G-type receptor 2 Conjugated Antibody |
|||
| C48039 | SAB | 100ul | EUR 397 |
 Antibody) Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx129021 | Abbexa |
|
|
|
|||
 Antibody) Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx129487 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx129594 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx121346 | Abbexa |
|
|
|
|||
 Antibody) Cadherin EGF LAG Seven-Pass G-Type Receptor 1 (CELSR1) Antibody |
|||
| 20-abx149215 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx104425 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx015220 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| abx019031-100ug | Abbexa | 100 ug | EUR 342 |
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx175642 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx323144 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven-Pass G-Type Receptor 1 (CELSR1) Antibody |
|||
| 20-abx326358 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| 20-abx326373 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx326797 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx214881 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody |
|||
| abx330317-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
Cadherin EGF LAG Seven-Pass G-Type Receptor 1 (CELSR1) Antibody |
|||
| abx331288-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx241634 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx171501 | Abbexa |
|
|
|
|||
Cadherin EGF LAG Seven Pass G-Type Receptor 2 (CELSR2) Antibody |
|||
| 20-abx171502 | Abbexa |
|
|
|
|||
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
) Yeast Live-or-Dye Fixable Live/Dead Staining Kit (TO and Live-or-Dye 568/583) |
|||
| 31064 | Biotium | 1kit | EUR 439 |
|
Description: Minimum order quantity: 1 unit of 1kit |
|||
 Antibody) Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| 20-abx123847 | Abbexa |
|
|
|
|||
Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| 20-abx125566 | Abbexa |
|
|
|
|||
 Antibody) Basic Helix Loop Helix Domain Containing Protein B3 (BHLHB3) Antibody |
|||
| 20-abx119079 | Abbexa |
|
|
|
|||
 Antibody) Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody |
|||
| 20-abx111184 | Abbexa |
|
|
|
|||
Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| 20-abx111185 | Abbexa |
|
|
|
|||
 Antibody) Class B Basic Helix-Loop-Helix Protein 3 (BHLH3) Antibody |
|||
| abx032604-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Class B Basic Helix-Loop-Helix Protein 3 (BHLH3) Antibody |
|||
| abx032604-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody |
|||
| 20-abx005013 | Abbexa |
|
|
|
|||
 Antibody) Class A Basic Helix-Loop-Helix Protein 9 (BHLHA9) Antibody |
|||
| abx030549-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Class A Basic Helix-Loop-Helix Protein 9 (BHLHA9) Antibody |
|||
| abx030549-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 Antibody) Basic Helix Loop Helix Domain Containing Protein B8 (BHLHB8) Antibody |
|||
| 20-abx175534 | Abbexa |
|
|
|
|||
Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| 20-abx328911 | Abbexa |
|
|
|
|||
Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| 20-abx338572 | Abbexa |
|
|
|
|||
 Antibody) Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody |
|||
| 20-abx334320 | Abbexa |
|
|
|
|||
Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody |
|||
| abx431589-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
 Antibody) Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) Antibody |
|||
| abx432405-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) Antibody |
|||
| abx432406-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody |
|||
| abx237869-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody |
|||
| 20-abx302086 | Abbexa |
|
|
|
|||
 Antibody) Class A Basic Helix-Loop-Helix Protein 15 (BHLHA15) Antibody |
|||
| abx230886-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) Antibody |
|||
| abx230887-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody |
|||
| abx230888-100ug | Abbexa | 100 ug | EUR 481 |
|
|||
Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody |
|||
| abx230889-100ug | Abbexa | 100 ug | EUR 481 |
|
|||
Basic Helix Loop Helix Domain Containing Protein B8 (BHLHB8) Antibody |
|||
| 20-abx171385 | Abbexa |
|
|
|
|||
 antibody) Anti-EPB41L2 / 4.1G (aa 593 to 604) antibody |
|||
| STJ71353 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-EPB41L2 / 4.1G (aa 347 to 357) antibody |
|||
| STJ71367 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-C2GnT-M (aa 410 to 422) antibody |
|||
| STJ71415 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-C2GnT-M (aa 273 to 284) antibody |
|||
| STJ71416 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-TUSC4 / NPRL2 (aa 140 to 151) antibody |
|||
| STJ71427 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-BDH2 / DHRS6 (aa 60 to 71) antibody |
|||
| STJ71434 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-RIG1 / RARRES3 (aa 124 to 136) antibody |
|||
| STJ71469 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-BDH2 / DHRS6 (aa 92 to 103) antibody |
|||
| STJ71470 | St John's Laboratory | 100 µg | EUR 260 |
 Antibody) ATF2 (pS62 or 44) Antibody |
|||
| abx012094-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Antibody) ATF2 (pS112 or 94) Antibody |
|||
| abx012095-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Antibody) ATF2 (pT69 or 51) Antibody |
|||
| abx012096-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Antibody) ATF2 (pT71 or 53) Antibody |
|||
| abx012097-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Antibody) ATF2 (pT73 or 55) Antibody |
|||
| abx012098-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Polyclonal Antibody (Human)) Related To Receptor Tyrosine Kinase (RYK) Polyclonal Antibody (Human) |
|||
| 4-PAM129Hu01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Human Related To Receptor Tyrosine Kinase (RYK) |
|||
 Antibody) Seven In Absentia Homolog 1 (Drosophila) Antibody |
|||
| 20-abx115496 | Abbexa |
|
|
|
|||
 ELISA Kit) Mouse EGF, Latrophilin Seven Transmembrane Domain-Containing Protein 1 (ELTD1) ELISA Kit |
|||
| abx556119-96tests | Abbexa | 96 tests | EUR 668 |
|
|||
){kind=spacer} Polyclonal GALR2 / Galanin Receptor 2 Antibody (Transmembrane Domain) |
|||
| APR11992G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GALR2 / Galanin Receptor 2 (Transmembrane Domain). This antibody is tested and proven to work in the following applications: |
|||
 T Cell Receptor Associated Transmembrane Adaptor 1 Antibody |
|||
| 20-abx115973 | Abbexa |
|
|
|
|||
 Antibody) Tyrosine-Protein Kinase Transmembrane Receptor ROR1 (ROR1) Antibody |
|||
| 20-abx110323 | Abbexa |
|
|
|
|||
 Antibody) Tyrosine-Protein Kinase Transmembrane Receptor ROR2 (ROR2) Antibody |
|||
| abx224060-100ug | Abbexa | 100 ug | EUR 411 |
|
|||
 Tyrosine-protein kinase transmembrane receptor ROR1 Polyclonal Antibody |
|||
| 42311-100ul | SAB | 100ul | EUR 333 |
 Antibody) Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 4 (CHCHD4) Antibody |
|||
| 20-abx123495 | Abbexa |
|
|
|
|||
 Antibody) Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| 20-abx123560 | Abbexa |
|
|
|
|||
 Antibody) Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 4 (Chchd4) Antibody |
|||
| 20-abx111742 | Abbexa |
|
|
|
|||
 Antibody) Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 (CHCHD6) Antibody |
|||
| 20-abx111743 | Abbexa |
|
|
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 4 (CHCHD4) Antibody |
|||
| 20-abx109327 | Abbexa |
|
|
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 (CHCHD6) Antibody |
|||
| 20-abx002540 | Abbexa |
|
|
|
|||
 Antibody) Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10 (CHCHD10) Antibody |
|||
| abx028724-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10 (CHCHD10) Antibody |
|||
| abx028724-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 (CHCHD6) Antibody |
|||
| abx029848-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 (CHCHD6) Antibody |
|||
| abx029848-80l | Abbexa | 80 µl | EUR 286 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| 20-abx322584 | Abbexa |
|
|
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| 20-abx322585 | Abbexa |
|
|
|
|||
 Antibody) Conserved Helix-Loop-Helix Ubiquitous Kinase Phospho-Thr23 (CHUK pT23) Antibody |
|||
| 20-abx328997 | Abbexa |
|
|
|
|||
 Antibody (HRP)) Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody (HRP) |
|||
| 20-abx314059 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody (FITC) |
|||
| 20-abx314060 | Abbexa |
|
|
|
|||
 Antibody (Biotin)) Class E Basic Helix-Loop-Helix Protein 40 (BHLHE40) Antibody (Biotin) |
|||
| 20-abx314061 | Abbexa |
|
|
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| abx340011-100ug | Abbexa | 100 ug | EUR 391 |
|
|||
 Antibody (HRP)) Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody (HRP) |
|||
| 20-abx337703 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody (FITC) |
|||
| 20-abx337704 | Abbexa |
|
|
|
|||
 Antibody (Biotin)) Class E Basic Helix-Loop-Helix Protein 15 (SIM2) Antibody (Biotin) |
|||
| 20-abx337705 | Abbexa |
|
|
|
|||
 Antibody (HRP)) Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody (HRP) |
|||
| 20-abx335115 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody (FITC) |
|||
| 20-abx335116 | Abbexa |
|
|
|
|||
 Antibody (Biotin)) Class E Basic Helix-Loop-Helix Protein 41 (BHLHE41) Antibody (Biotin) |
|||
| 20-abx335117 | Abbexa |
|
|
|
|||
Conserved Helix-Loop-Helix Ubiquitous Kinase Phospho-Thr23 (CHUK pT23) Antibody |
|||
| abx333287-100ul | Abbexa | 100 ul | EUR 467 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| abx431889-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| abx432065-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 10 (CHCHD10) Antibody |
|||
| abx231634-100ug | Abbexa | 100 ug | EUR 481 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 3 (CHCHD3) Antibody |
|||
| abx231636-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 4 (CHCHD4) Antibody |
|||
| abx231637-100ug | Abbexa | 100 ug | EUR 481 |
|
|||
Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 (CHCHD6) Antibody |
|||
| abx231638-100ug | Abbexa | 100 ug | EUR 481 |
|
|||
 Antibody Pair to ApoA-V antibody |
|||
| 10R-1876 | Fitzgerald | 100 ul | EUR 651 |
|
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
|||
 Antibody) Polyclonal Goat Anti-GOT2 (aa 295 to 306) Antibody |
|||
| AMM04997G | Leading Biology | 0.1 mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GOT2 (aa 295 to 306) . This antibody is tested and proven to work in the following applications: |
|||
 Antibody) Polyclonal Goat Anti-GOT2 (aa 360 to 373) Antibody |
|||
| AMM04998G | Leading Biology | 0.1 mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GOT2 (aa 360 to 373) . This antibody is tested and proven to work in the following applications: |
|||
 Antibody) Polyclonal Goat Anti-Renalase (aa 134 to 147) Antibody |
|||
| AMM05956G | Leading Biology | 0.1 mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Renalase (aa 134 to 147) . This antibody is tested and proven to work in the following applications: |
|||
 Antibody) Polyclonal Goat Anti-Renalase (aa 224 to 233) Antibody |
|||
| APG03367G | Leading Biology | 0.1 mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Renalase (aa 224 to 233) . This antibody is tested and proven to work in the following applications: |
|||
 antibody) Anti-TEB4 / MARCH-VI (aa 886 to 898) antibody |
|||
| STJ71362 | St John's Laboratory | 100 µg | EUR 359 |
 antibody) Anti-TEB4 / MARCH-VI (aa 701 to 712) antibody |
|||
| STJ71436 | St John's Laboratory | 100 µg | EUR 359 |
 Antibody) CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC610988-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC610988-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC400988-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC400988-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC430988-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC430988-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC470988-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC470988-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD54(1H4 or Wehi-CAM-1 or W-CAM-1) Antibody |
|||
| BNC550988-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD54(1H4 or Wehi-CAM-1 or W-CAM-1), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Right here we present {that a} transmembrane protein, Semi1, is essential for attachment. Lack of Semi1 causes failure to connect and consequent infertility. Nevertheless, a nucleus is chosen and provides rise to pronuclei no matter Semi1 expression, indicating that attachment of a nucleus to the junction just isn’t a precondition for choice however follows the choice course of.
